Regenerative Medicine Weekly Trend Line
June 11th, 2011
No comments
Shares of regenerative medicine stem cell companies were AGAIN off due to macro issues and negative market gyrations. Read more…
Archive
Archive for the ‘Stem Cell Research’ Category
The RegMed Daily Dialogue, 6/9/11, News is flowing, Highlighting the sector
June 9th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Categories: Regenerative Medicine, Stem Cell Research, The RegMed Daily Dialogue
BioTime (BTX) reports on 5 GMP-Compliant Human Embryonic Stem Cell Lines
June 9th, 2011
No comments
Complete sequencing of DNA shows normality of the cells and their suitability for clinical use Read more…
Roche and UCLA Stem Cell Researchers Agreement
June 9th, 2011
No comments
An agreement between UCLA and Roche (SIX: RO, ROG; OTCQX: RHHBY) will provide stem cell and cancer researchers with Read more…
Extending the Controversy, Kyoto professor blasts iPS cell research paper
June 8th, 2011
No comments
Kyoto University professor Shinya Yamanaka, an expert in induced pluripotent stem cells, said Read more…
Categories: induced pluripotent stem (iPS) cells, Stem Cell Research
The RegMed Daily Dialogue, 6/8/11, Short term summer blues – we HOPE
June 8th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Categories: Regenerative Medicine, Stem Cell Research, The RegMed Daily Dialogue
The RegMed Daily Dialogue, 6/7/11, A Consequential move but Pessimism is still pervasive
June 7th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Categories: Regenerative Medicine, Stem Cell Research, The RegMed Daily Dialogue
The RegMed Daily Dialogue, 6/6/11, The June Swoon is On
June 6th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Categories: Regenerative Medicine, Stem Cell Research, The RegMed Daily Dialogue
Regenerative Medicine Weekly Trend Line
June 4th, 2011
Comments off
Shares of regenerative medicine stem cell companies were off due to macro issues and negative government data. Read more…
The RegMed Daily Dialogue, 6/3/11, Continued Mixed Signals
June 3rd, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
Categories: Regenerative Medicine, Stem Cell Research, The RegMed Daily Dialogue
Henry W. McCusker
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.